The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 19, 2018
Filed:
May. 21, 2014
Applicant:
Amira Pharmaceuticals, Inc., Princeton, NJ (US);
Inventors:
Ryan Clark, San Diego, CA (US);
Brian Andrew Stearns, Encinitas, CA (US);
Lucy Zhao, San Diego, CA (US);
Thomas Jon Seiders, San Diego, CA (US);
Deborah Volkots, New York, NY (US);
Jeannie M. Arruda, San Diego, CA (US);
Assignee:
AMIRA PHARMACEUTICALS, INC., Princeton, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/04 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01); C07D 231/38 (2006.01); C07D 261/08 (2006.01); C07D 261/14 (2006.01); C07D 417/12 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
C07D 231/38 (2013.01); C07D 261/08 (2013.01); C07D 261/14 (2013.01); C07D 413/04 (2013.01); C07D 413/06 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01);
Abstract
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.